Thompson; Karen C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Thompson; Karen C..The latest application filed is for "cb-1 receptor modulator pharmaceutical formulations".
- Thompson; Karen C. - Lansdale PA
| Patent | Date |
|---|---|
| Pharmaceutical composition of a tachykinin receptor antagonist Grant 8,258,132 - Bosch , et al. September 4, 2 | 2012-09-04 |
| Cb-1 Receptor Modulator Pharmaceutical Formulations App 20100081642 - Dokou; Eleni ; et al. | 2010-04-01 |
| Compressed tablet formulation Grant 7,595,063 - Batra , et al. September 29, 2 | 2009-09-29 |
| Synthesis and crystalline forms of melanocortin-4 receptor agonist App 20090131465 - Chen; Alex M. ; et al. | 2009-05-21 |
| Compressed tablet formulation App 20060188570 - Batra; Udit ; et al. | 2006-08-24 |
| Compressed tablet formulation Grant 7,060,294 - Batra , et al. June 13, 2 | 2006-06-13 |
| Formulations for tyrosine kinase inhibitors App 20060093666 - Karki; Shyam B. ; et al. | 2006-05-04 |
| Pharmaceutical composition of a tachykinin receptor antagonist App 20040214746 - Bosch, H. William ; et al. | 2004-10-28 |
| Compressed tablet formulation App 20020076436 - Batra, Udit ; et al. | 2002-06-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 